Our Research

The Purdue Institute for Cancer Research (PICR) has some of the best investigative minds in the world gathered in one place. More than 110 researchers across the university share ideas, insights and findings to drive cancer research further than any single laboratory could do alone. Together, they focus on a shared goal: creating a world without cancer. 

A National Cancer Institute-designated basic science cancer center, PICR is among the most efficient and prolific in the nation. It is responsible for 18 cancer drugs currently in the pipeline, including 5 drugs in clinical trials, 13 drugs in preclinical testing, and 21 additional compounds poised to enter preclinical development. Technology stemming from research at the institute has generated 14 startup companies within the past five years alone. 

Research programs within the center focus on basic research that advances cancer prevention, detection, diagnosis and treatment. Explore our programs. 

The institute's Shared Resources for researchers are critical to our ultimate goal of putting an end to cancer. We’re using cutting-edge equipment and facilities, providing access to the most up-to-date expertise and making innovative use of our abundant partnerships. Check out our Shared Resources.

Finally, we have several exciting opportunities to contribute to the world-leading developments happening at the institute. Learn more about ways to support our research.